Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06435923 | A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants | PHASE1 | COMPLETED | 8 | — | — | May 1, 2024 | Jul 1, 2024 | Jul 30, 2024 | - | — |
| NCT05824143 | Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants | PHASE1 | COMPLETED | 13 | — | — | Apr 1, 2023 | Jul 1, 2023 | Aug 2, 2023 | - | — |
| Name | Type | Description |
|---|---|---|
| [14C]-darigabat | DRUG | Oral capsule |
| Darigabat | DRUG | Oral tablet |
| Carbamazepine | DRUG | Oral tablets |